NDC 65862-0745-30
Galantamine 16 mg/1 CAPSULE, EXTENDED RELEASE
Available — 2-Day Shipping
NDC
65862-0745-30
Generic Name
Galantamine
Brand Name
Galantamine
Strength
16 mg/1
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Package Size
—
Labeler
Aurobindo Pharma Limited
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Galantamine extended-release capsules are indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. Galantamine extended-release capsules are a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type (1)
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Galantamine Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 65862-0745-30 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).